DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mass drug administration
Mass drug administration
WHO Technical Consultation to Review the Role of Drugs in Malaria Prevention for People Living in Endemic Settings
Download
The Safety and Effectiveness of Single Dose Primaquine As a P
Meeting Report of the WHO Evidence Review Group on Mass Drug Administration for Malaria
Understanding Adherence to Reactive Treatment of Asymptomatic Malaria
Review of Mass Drug Administration and Primaquine
A Guide for Independent Monitoring of Mass Drug Administration for Neglected Tropical Disease Control
Mass Drug Administration, Mass Screening and Treatment and Focal Screening and Treatment for Malaria
The Challenge of Schistosomiasis Frank O Richards Jr,A Abel Eigege,B Emmanuel S Miri,B MY Jinadu,C & Donald R Hopkins A
Envisage Repurposing Ivermectin for SARS-COV-2
G6PD Deficiency in Latin America: Systematic Review on Prevalence and Variants
Lymphatic Filariasis: Elimination in the Americas
Evaluation of Mass Drug Administration Impact on Transmission of Lymphatic Filariasis in 13 Sanitary Districts in Burkina Faso
Impact of Five Annual Rounds of Mass Drug Administration with Ivermectin on Onchocerciasis in Sierra Leone Joseph B
Glucose-6-Phosphate Dehydrogenase Deficiency Prevalence and Genetic
G6PD Deficiency: a Classic Example of Pharmacogenetics with Ongoing Clinical Implications
Weekly Epidemiological Record Relevé Épidémiologique Hebdomadaire
Mass Drug Administration – When Is It Useful
Top View
Factors Influencing Involvement in Mass Drug
Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis Wilma A
Perception of Malaria Chemoprevention Interventions in Infants and Children in Eight Sub-Saharan African Countries: an End User Perspective Study
Medicines Alone Cannot Ensure the Treatment of Neglected Tropical Diseases
Evaluation of the WHO Neglected Tropical Diseases Programme
The Neglected Tropical Diseases: a Rags-To- Riches Story Ten Years in Public Health 2007–2017
Guideline: Alternative Mass Drug Administration Regimens to Eliminate Lymphatic Filariasis
Lymphatic Filariasis: Elimination in the Americas
Mass Drug Administration: WHO Policy Update
Lymphatic Filariasis in Peninsular Malaysia
Prevalence of Malaria and Glucose-6-Phosphate
Mass Drug Administration for Malaria a Practical Field Manual
Mass Drug Administration for Malaria Elimination: Do We Understand the Settings Well Enough? Manuel W
Lessons from Implementing Mass Drug Administration for Soil
Editorial the Role of Mass Drug Administration of Antimalarials
Correlates of Non-Participation in Mass Drug Administration Against Neglected Tropical Diseases in the Assin North Municipality in the Central Region of Ghana
Safety and Effectiveness of Mass Drug Administration to Accelerate
Artemisinin Combination Therapy Mass Drug Administration in A
Piloting Triple-Drug Therapy in Kenya Table of Contents
Factors Associated with Non-Participation and Non-Adherence in Directly Observed Mass Drug Administration for Malaria in the Gambia
Mass Drug Administration for Falciparum Malaria
Burkina Faso
Malaria Resurgence After Significant Reduction by Mass Drug
Review of Mass Drug Administration and Primaquine Use
Mass Drug Administration for Falciparum Malaria
Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: an Active Surveillance Study
Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency in Southern Province, Zambia
Using Diethylcarbamazine-Fortified Salt to Eliminate Lymphatic Filariasis Patrick Lammie,A Trevor Milner B & Robin Houston C
Assessing Knowledge About Lymphatic Filariasis and the Implementation Of
Burkina Faso Work Plan FY2012